TIMOTHY MARTIN: Open Payments
NPI 1336601723 · KOKOMO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 7 payments from 4 companies in 2025. Trend: 2023 $241 · 2024 $47 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $62 |
| ABBVIE INC. | 3 | $54 |
| Alkermes, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: VRAYLAR, VIVITROL, GEMTESA.
Industry payments across MS — which companies pay providers there.
